Multiple endocrine neoplasia type 2: A review

Keyphrases

• Aerodigestive Tract 33%
• Autosomal Dominant 33%
• Clinical Entities 33%
• Clinical Management 33%
• Family Members 33%
• Gain-of-function 33%
• Ganglioneuromatosis 33%
• Genetic Counseling 66%
• Genetic Variants 33%
• Genotype 33%
• Genotype-phenotype Association 33%
• Germ Cells 33%
• Germline Variants 33%
• Hereditary Cancer Syndromes 33%
• Hereditary Disease 66%
• High Variability 33%
• Hirschprung's Disease 33%
• Lichen Amyloidosis 33%
• Malignant Potential 33%
• Medullary Thyroid Carcinoma 66%
• MEN2B 66%
• Multiple Endocrine Neoplasia Type 1 (MEN1) 33%
• Multiple Endocrine Neoplasia Type 2 (MEN2) 100%
• Musculoskeletal Abnormalities 33%
• Oncogene 33%
• Ophthalmic Abnormalities 33%
• Pheochromocytoma 66%
• Primary Hyperparathyroidism (pHPT) 33%
• Rearranged during Transfection 66%
• Risk Classification 33%
• Treatment Timing 33%

Medicine and Dentistry

• Amyloidosis 33%
• Autosomal Dominant Inheritance 33%
• Clinical Management 33%
• Disease 33%
• Familial Cancer 33%
• Ganglioneuroma 33%
• Genetic Counseling 66%
• Genetic Transfection 66%
• Genetic Variability 33%
• Lichen (Disease) 33%
• Multiple Endocrine Neoplasia 33%
• Multiple Endocrine Neoplasia Type 2 100%
• Pheochromocytoma 66%
• Primary Hyperparathyroidism 33%
• Proto Oncogene 33%
• Thyroid Medullary Carcinoma 66%